Filing Details

Accession Number:
0001209191-16-119379
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-11 21:23:05
Reporting Period:
2016-05-09
Filing Date:
2016-05-11
Accepted Time:
2016-05-11 21:23:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615466 Jesus Alzarez 800 W. Olympic Blvd.
Los Angeles CA 90015
Vp, General Manager, Mexico No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-09 1,042 $53.29 1,042 No 4 M Direct
Common Stock Acquisiton 2016-05-09 3,934 $44.79 4,976 No 4 M Direct
Common Stock Acquisiton 2016-05-09 1,957 $30.44 6,933 No 4 M Direct
Common Stock Disposition 2016-05-09 4,661 $62.51 2,272 No 4 D Direct
Common Stock Disposition 2016-05-09 797 $62.51 1,475 No 4 F Direct
Common Stock Disposition 2016-05-11 875 $62.19 600 No 4 S Direct
Common Stock Disposition 2016-05-11 600 $62.18 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2016-05-09 1,042 $0.00 1,042 $53.29
Common Stock Stock Appreciation Rights Disposition 2016-05-09 3,934 $0.00 3,934 $44.79
Common Stock Stock Appreciation Rights Disposition 2016-05-09 1,957 $0.00 1,957 $30.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-05-18 2021-05-18 No 4 M Direct
0 2015-05-31 2022-05-31 No 4 M Direct
0 2016-03-02 2025-03-02 No 4 M Direct
Footnotes
  1. The reporting person received an aggregate of 6,933 shares of common stock upon the net exercise of the stock appreciation rights ("SARS"). The reporting person forfeited an aggregate of 4,661 shares of common stock underlying the SARS in payment of the exercise price and an aggregate of 797 shares of common stock underlying the SARS to satisfy the aggregate withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2016 of $62.51.